Cagrilintide & Semaglutide in Overweight Adults (REDEFINE-1) | NEJM US$ 21.87 Min. order: 1 piece ★★★★★ 4.2 (109 reviews) Sold : Login>>
CagriSema (Cagrilintide–Semaglutide) in Adults with Overweight or Obesity and Type 2 Diabetes US$ 26.89 Min. order: 1 piece ★★★★★ 5.0 (76 reviews) Sold : Login>>
BPC-157: Miracle Healing Peptide or Hidden Danger? US$ 28.90 Min. order: 1 piece ★★★★★ 4.6 (50 reviews) Sold : Login>>
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial US$ 27.45 Min. order: 1 piece ★★★★★ 4.5 (50 reviews) Sold : Login>>
CagriSema Dual-Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist), designed to influence key metabolic and appetite-regulating pathways. Current US$ 29.35 Min. order: 1 piece ★★★★★ 4.9 (22 reviews) Sold : Login>>